The Cox proportional hazard regression showed that the adjusted HR of pneumonia during the 1-year follow-up period for PC patients who received treatment with GnRH agonists was 2.23 (95% CI: 1.30∼3.82) compared to PC patients who did not receive treatment with GnRH agonists. Here, GNRH1 is linked to susceptibility to pneumonia measurement.